Cite
MLA Citation
N Ghaffarpour et al.. “Patients with lymphatic malformations who receive the immunostimulant OK‐432 experience excellent long‐term outcomes.” Acta pædiatrica, vol. 104, n.d., pp. 1169–1173. http://access.bl.uk/ark:/81055/vdc_100026691480.0x000011